Article

Nouvelles techniques interventionnelles radiologiques dans le traitement des douleurs d’origine cancéreuse: infiltration, alcoolisation, vertébroplastie, cimentoplastie, radiofréquence bipolaire Algoradiologie interventionnelle de la douleur cancéreuse

Laboratoire d’imagerie et d’ingénierie pour la santé, LE2i UMR 515 CNRS, Besançon, France
Douleur et Analgésie (Impact Factor: 0.09). 01/2007; 20(1):27-42. DOI: 10.1007/s11724-007-0032-9

ABSTRACT La prise en charge de la douleur cancéreuse souvent révélatrice et toujours présente à un moment donné de la maladie est un
challenge thérapeutique en particulier à un stade évolué. La composante douloureuse ne répond pas toujours aux antalgiques
majeurs, à la chimiothérapie et à la radiothérapie. Quand ces traitements sont dépassés, les infiltrations, neurolyses, alcoolisations,
la vertébroplastie, la cimentoplastie et la radiofréquence par voie percutanée sont des méthodes élégantes et efficaces venant
en complément des traitements classiques. Les auteurs présentent ici leur expertise dans ces nouvelles techniques sous contrôle
tomodensitométrique qu’ils ont contribué à mettre au point.
Bone invasion by metastatic tumours is the most common cause of pain in cancer patients. The management of cancer pain, pain
that often reveals the disease and is always present at advanced stages, is an important and difficult task. High doses of
specific medications, chemotherapy and radiation therapy do not always succeed in effectively controlling pain. When these
treatments do not provide adequate relief, neurolysis, infiltration, alcoholization, percutaneous vertebroplasty, cementoplasty,
and radiofrequency ablation are elegant and efficient complementary alternative pain management methods. The authors helped
to develop these new techniques, which rely on CT guidance, and offer their expertise in how to apply them.

0 Followers
 · 
183 Views
 · 
0 Downloads
  • [Show abstract] [Hide abstract]
    ABSTRACT: The World Health Organisation (WHO) guidelines to fight cancer pain are effective to relieve most of nociceptive pains. Strong opioids are often used efficiently; however, a significant proportion of patients taking opioid do not see successful outcomes and have to switch to alternative strong opioid. This rotation is a maneuver aiming at improving analgesic response and/or reducing adverse effects. In this review, indications, principles, strong opioid dose conversion recommendations and guidelines for patients with cancer are presented. The different galenics available in France are also outlined.
    Médecine Palliative Soins de Support - Accompagnement - Éthique 02/2009; 8(1). DOI:10.1016/j.medpal.2008.12.001
  • [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this study is to assess the interest of cementoplasty in the management of bone metastases, based on a retrospective study involving 42 cementoplasty procedures. The median age of the patients is 59 years, with 24 women (57%) and 18 men, all of them presenting with an advanced disease. The cementoplasty was situated in long bones (ten patients), dorsal or lumbar vertebrae (13) and flat bones (20). The principal indication was pain, sometimes with consolidation. The intensity of pain decreases between the day before and the month following the treatment (P = 0.04) among the 25 patients who had pain assessment before and after the procedure. We note 57% good results (24 patients), 9.5% failures (4 patients), and 31% with partial results (13 patients), that is, a total of 88% with "partial or full" alleviation. 16 patients out of 22 (73%) who were no longer able to walk (because of the pain or risk of fracture) were able to resume walking. We observed in this series 40.5% of complications, all of them benign. Cementoplasty improves the quality of life of patients with bone metastases, by decreasing the pain in 88% of cases and allowing the resumption of walking in almost three-quarters of the patients who had lost the ability to walk.
    Medical Oncology 04/2011; 29(2):1378-83. DOI:10.1007/s12032-011-9939-3 · 2.06 Impact Factor